Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 3
1996 1
1998 2
2000 2
2001 3
2002 2
2003 4
2004 3
2005 4
2006 7
2007 1
2008 2
2009 4
2010 2
2012 3
2013 1
2014 2
2015 1
2016 1
2017 2
2020 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Genetically engineered probiotics.
Steidler L. Steidler L. Best Pract Res Clin Gastroenterol. 2003 Oct;17(5):861-76. doi: 10.1016/s1521-6918(03)00072-6. Best Pract Res Clin Gastroenterol. 2003. PMID: 14507594 Review.
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
Mathieu C, Wiedeman A, Cerosaletti K, Long SA, Serti E, Cooney L, Vermeiren J, Caluwaerts S, Van Huynegem K, Steidler L, Blomme S, Rottiers P, Nepom GT, Herold KC; AG019-T1D-101 Trial Investigators. Mathieu C, et al. Among authors: steidler l. Diabetologia. 2024 Jan;67(1):27-41. doi: 10.1007/s00125-023-06014-2. Epub 2023 Oct 2. Diabetologia. 2024. PMID: 37782353 Free PMC article. Clinical Trial.
Immunomodulation by genetically engineered lactic acid bacteria.
Van Huynegem K, Loos M, Steidler L. Van Huynegem K, et al. Among authors: steidler l. Front Biosci (Landmark Ed). 2009 Jun 1;14(13):4825-35. doi: 10.2741/3571. Front Biosci (Landmark Ed). 2009. PMID: 19482589 Free article. Review.
Engineering lactococci and lactobacilli for human health.
Bermúdez-Humarán LG, Aubry C, Motta JP, Deraison C, Steidler L, Vergnolle N, Chatel JM, Langella P. Bermúdez-Humarán LG, et al. Among authors: steidler l. Curr Opin Microbiol. 2013 Jun;16(3):278-83. doi: 10.1016/j.mib.2013.06.002. Epub 2013 Jul 11. Curr Opin Microbiol. 2013. PMID: 23850097 Review.
Delivery of therapeutic proteins through Lactococcus lactis.
Neirynck S, Steidler L. Neirynck S, et al. Among authors: steidler l. Biotechnol Genet Eng Rev. 2006;22:253-66. doi: 10.1080/02648725.2006.10648073. Biotechnol Genet Eng Rev. 2006. PMID: 18476334 Review. No abstract available.
Clinical development of lactocepin: a novel bacterial biologic?
Van Huynegem K, Steidler L. Van Huynegem K, et al. Among authors: steidler l. Expert Rev Clin Immunol. 2012 Sep;8(7):597-9. doi: 10.1586/eci.12.55. Expert Rev Clin Immunol. 2012. PMID: 23078055 No abstract available.
52 results